Diversified Healthcare Trust furnishes Q3 2025 results materials

Rhea-AI Filing Summary

Diversified Healthcare Trust furnished an update on its business by announcing financial results for the quarter ended September 30, 2025. The company provided a summary press release and a detailed earnings presentation to accompany the results, making them available as Exhibits 99.1 and 99.2. This 8‑K is limited to distributing those materials and does not itself include the underlying figures.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001075415false00010754152025-11-032025-11-030001075415dhc:SeniorNotesDue2042Member2025-11-032025-11-030001075415dhc:SeniorNotesDue2046Member2025-11-032025-11-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC  20549

FORM 8-K 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): November 3, 2025

DIVERSIFIED HEALTHCARE TRUST

(Exact Name of Registrant as Specified in Its Charter)

Maryland

(State or Other Jurisdiction of Incorporation) 

001-15319						04-3445278
(Commission File Number)						(IRS Employer Identification No.)

Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458-1634

(Address of Principal Executive Offices) (Zip Code)

617-796-8350

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title Of Each Class

Trading Symbol(s)

Name Of Each Exchange On Which Registered

Common Shares of Beneficial Interest

DHC

The Nasdaq Stock Market LLC

5.625% Senior Notes due 2042

DHCNI

The Nasdaq Stock Market LLC

6.25% Senior Notes due 2046

DHCNL

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 2.02.  RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On November 3, 2025, Diversified Healthcare Trust, or the Company, issued a summary press release and a detailed earnings presentation announcing the Company's financial results for the quarter ended September 30, 2025. Copies of the Company's summary press release and detailed earnings presentation are furnished as Exhibits 99.1 and 99.2 hereto, respectively.

ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS.

(d)        Exhibits.

99.1			Summary Press Release dated November 3, 2025
99.2			Earnings Presentation dated November 3, 2025
104			Cover Page Interactive Data File. (Embedded within the Inline XBRL document.)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			DIVERSIFIED HEALTHCARE TRUST
			By:			/s/ Matthew C. Brown
			Name:			Matthew C. Brown
			Title:			Chief Financial Officer and Treasurer

Dated:  November 3, 2025

FAQ

What did DHC disclose in this 8-K?

The company announced financial results for the quarter ended September 30, 2025 and furnished a summary press release (Exhibit 99.1) and an earnings presentation (Exhibit 99.2).

Which period do the DHC results cover?

The results cover the quarter ended September 30, 2025.

Are detailed numbers included in this 8-K for DHC?

The filing furnishes a press release and an earnings presentation with details; the 8-K text itself does not present the figures.

What exhibits did DHC include with this filing?

Exhibit 99.1 is a summary press release dated November 3, 2025, and Exhibit 99.2 is an earnings presentation dated November 3, 2025.

What is DHC’s trading symbol and where is it listed?

Common shares trade as DHC on The Nasdaq Stock Market LLC.

What other DHC securities are listed?

5.625% Senior Notes due 2042 trade as DHCNI, and 6.25% Senior Notes due 2046 trade as DHCNL on The Nasdaq Stock Market LLC.